ArticleCancers2023

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.

Holger N Lode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.